Gabapentin and opioids together: the breathing risk explained

Pain management rarely arrives as a single prescription. After surgery, an injury or a flare of chronic pain, it is common to leave the pharmacy with an opioid for the sharp pain and gabapentin for the nerve component. On paper the pairing makes sense. Each drug targets a different pain pathway, and for years some clinicians hoped the combination would let patients use less opioid overall.

The hidden problem is what both drugs do to the same body system: the drive to breathe. Regulators, researchers and emergency physicians have now spent several years documenting that when gabapentin and opioids are taken together, the risk of slowed or stopped breathing can rise, sometimes sharply. This guide explains the gabapentin and opioid breathing risk step by step: what controls your breathing, how each drug interferes, what the evidence shows, who is most vulnerable and what practical safeguards actually reduce danger. It is educational and not a substitute for guidance from your care team.

Link one: how your body decides to breathe

Breathing feels automatic because it is. Clusters of neurons in the brainstem generate the rhythm, adjusting it moment to moment in response to carbon dioxide levels in the blood. When carbon dioxide rises, you breathe faster and deeper. When it falls, you slow down. This feedback loop works while you sleep, while you read and while you are unconscious.

Anything that dampens activity in those brainstem circuits makes the loop less responsive. Breaths become shallow or farther apart, carbon dioxide builds up and, in the worst case, oxygen drops to dangerous levels. Because the system is largely unconscious, people at risk usually cannot “decide” to breathe more when they feel drowsy. That is why respiratory depression tends to be silent and why it is most dangerous during sleep.

Link two: how opioids slow breathing

Opioids such as oxycodone, hydrocodone, morphine, codeine, tramadol and fentanyl bind mu-opioid receptors. Some of those receptors sit in the brainstem regions that control respiration. Activating them reduces the responsiveness to carbon dioxide and slows the breathing rhythm. It is the leading cause of death in opioid overdose, and it is dose-dependent. Our guides on oxycodone black box warnings and signs an oxycodone dose may be too high cover this in detail.

Link three: where gabapentin enters the picture

Gabapentin does not act on opioid receptors. It binds the α2δ subunit of voltage-gated calcium channels and reduces release of excitatory neurotransmitters. Taken alone and at ordinary doses, it generally does not suppress breathing in healthy people, which is why the FDA specifically noted there is less evidence of serious problems in that group. But under stress conditions, the picture changes.

The FDA’s 2019 review pulled together several lines of evidence. Two randomized, placebo-controlled trials found that pregabalin alone, and pregabalin with an opioid, could depress breathing function, and that gabapentin alone increased pauses in breathing during sleep. Several animal studies found that pregabalin and gabapentin have an independent, dose-dependent depressive effect on respiration and can add to the respiratory depression caused by opioids. The precise brain mechanism is not fully mapped, but the practical message is consistent: gabapentinoids add to the sedative burden, and in a person already near the edge, that can be enough.

Why the combination is more than addition

Two factors make the pairing especially tricky:

• Overlapping peaks. Oral gabapentin reaches peak blood levels a few hours after a dose, and many opioid formulations peak in a similar window. Evening doses of both can coincide with the deepest part of sleep, when breathing control is naturally least vigilant.
• Altered tolerance. Someone who has taken opioids for a long time develops tolerance to some of their effects, including respiratory depression. Adding gabapentin, or increasing it, can erode that cushion without the person noticing.

Link four: what the real-world data show

Beyond the FDA review, a population-based study from Ontario, Canada, published in PLOS Medicine in 2017, examined opioid users who died of opioid-related causes and compared them with matched opioid users who did not. People who were also prescribed gabapentin had roughly 49 percent higher odds of opioid-related death, and the risk appeared to rise with higher gabapentin doses. As an observational study, it cannot prove that gabapentin caused the deaths; people prescribed both drugs may differ in other ways. Still, the direction was consistent with the FDA’s concerns and with other studies that have linked co-prescription to overdose and emergency visits.

How common is the combination? The FDA cited an office-based physician survey from 2016 indicating that an estimated 14 percent of patient encounters involving gabapentin and 19 percent of those involving pregabalin also involved opioids. In other words, this is not a rare scenario. It is routine, which is exactly why understanding it matters.

Link five: who is most at risk

Situation	Why risk is higher
Adults over 65	Slower kidney clearance of gabapentin, greater sensitivity to sedatives, more other medications
COPD, asthma, sleep apnea or other lung conditions	Little respiratory reserve if drive to breathe falls
Reduced kidney function	Gabapentin accumulates; see gabapentin and kidney function
Also taking benzodiazepines, sleeping pills, muscle relaxants or sedating antihistamines	Multiple depressants stack their effects
Drinking alcohol	Alcohol is another respiratory depressant; see gabapentin and alcohol
Recent dose increase, new prescription or switch in product	Tolerance has not caught up
Misuse of either drug, or taking gabapentin to “boost” opioids	Doses are higher and unsupervised
Period right after surgery	Anesthesia aftereffects, multiple analgesics and reduced mobility

The opioids most often paired with gabapentin

Any opioid can raise the respiratory stakes with gabapentin, but some combinations appear more often in clinical practice. We cover them individually:

• Oxycodone and gabapentin
• Hydrocodone and gabapentin
• Gabapentin vs tramadol, a comparison of two drugs that are sometimes combined
• Oxycodone and sleep medications, relevant when a third sedative joins the mix

Spotting trouble early

Respiratory depression is easy to miss in someone who is simply “sleeping it off.” Learn the difference between ordinary drowsiness and an emergency.

Warning signs of dangerous sedation

• Breathing that is slow, shallow, irregular or interrupted by long pauses.
• Loud snoring or gurgling that is new, or choking sounds during sleep.
• Blue, gray or pale lips and fingertips.
• A person who cannot be roused by shaking or calling their name.
• Very small “pinpoint” pupils, which are common with opioids.
• A limp body, cold clammy skin or a weak pulse.

Subtler signs that call for a same-day call to the prescriber

• Morning headaches or unusual daytime sleepiness.
• Confusion, slurred speech or unsteadiness that is new.
• Shortness of breath at rest or when lying flat.
• Someone else noticing pauses in your breathing during sleep.

What to do in an emergency

1. Try to wake the person. Call loudly, shake their shoulders, rub the breastbone firmly.
2. Call emergency services. Do not wait to see if it improves. In the United States, dial 911.
3. Give naloxone if opioids may be involved and it is available. Naloxone reverses opioid effects and is available as a nasal spray, including over the counter in the United States. Be aware that it works on the opioid component and does not directly reverse gabapentin or other sedatives, so the person may need repeated doses and always needs emergency evaluation, even if they wake up.
4. Support breathing. If trained, begin rescue breathing or CPR as instructed by the dispatcher. Turn a breathing but unresponsive person onto their side in the recovery position to protect the airway.
5. Stay until help arrives and tell responders everything that was taken, including alcohol and over-the-counter products.

Households where someone takes opioids, with or without gabapentin, can reasonably keep naloxone on hand and make sure family members know where it is and how to use it. Ask your pharmacist for a demonstration.

Practical ways to lower the risk

If you are prescribed both

• Confirm that the combination is intentional. Ask each prescriber whether they know about the other drug, and ask your pharmacist to review the list.
• Use the lowest effective dose of each. Do not self-adjust. If pain is poorly controlled, call rather than adding extra doses.
• Be cautious with the bedtime dose. Ask whether timing should be changed so that peak effects do not overlap with the deepest sleep.
• Avoid alcohol entirely unless your clinician has explicitly said otherwise.
• Avoid other sedatives. That includes over-the-counter sleep aids, many cold and allergy remedies containing diphenhydramine or doxylamine, and anyone else’s pills.
• Do not drive or use machinery until you know how the combination affects you.
• Keep a shared medication list in your wallet or phone.

If you have lung disease or sleep apnea

Tell every prescriber. Some may choose a different pain strategy, and others may order sleep testing or monitoring before combining sedating drugs. If you use a CPAP machine, keep using it, and make sure the clinician knows about any breathing problem during sleep.

If a loved one takes both

Check on them during the first nights after a new prescription or dose increase. Learn the warning signs above, store medications securely out of reach of children, and avoid leaving large supplies in easily accessible places.

If you are tempted to use gabapentin to make opioids “hit harder”

This is a recognized misuse pattern and a particularly dangerous one. It increases overdose risk, and it is a good reason to seek help. In the United States, the SAMHSA National Helpline at 1-800-662-4357 provides free, confidential, 24-hour referrals for substance use treatment.

Why doctors sometimes prescribe both on purpose

It would be inaccurate to describe every opioid-plus-gabapentin prescription as a mistake. After certain surgeries, protocols that combine several non-opioid and opioid-sparing medications can reduce the total opioid needed, and gabapentin has been part of some of those pathways. In chronic neuropathic pain, gabapentin may be added precisely because it is hoped that the opioid dose can come down. The American Geriatrics Society, for example, notes limited exceptions to its general advice against combining the two, including situations where gabapentin is used to help taper an opioid.

The issue is not that the combination is forbidden. It is that it requires a plan: clear indication, careful dosing, kidney awareness, patient education and follow-up. A patient who has been told what to watch for is far safer than one who was simply handed two bottles.

The high-risk windows

Risk is not spread evenly across time. Certain moments deserve extra attention because tolerance, dosing and monitoring are all in flux:

• The first days after starting either drug. The body has not adapted, and the person has not yet learned how they react.
• Any dose increase. This includes small bumps and switching to a stronger tablet.
• Changing formulations. A move from immediate-release to extended-release opioid, or a change in gabapentin product, can alter peak levels.
• Illness. A vomiting bug or infection can reduce kidney function, causing gabapentin to build up. See gabapentin and kidney function.
• Night-time. Breathing control weakens naturally during sleep, and the last doses of the day often peak while the person is asleep and unobserved.
• Periods after a break. Resuming a prior dose after days or weeks without the opioid is hazardous because tolerance has faded.
• Travel and disrupted routines. Missed doses, double-ups and alcohol with meals are common when routines change.

Three illustrative scenarios

The following are fictional composites meant to show how the risk plays out. They are not individual medical advice.

Scenario one: the post-surgery weekend

A sixty-eight-year-old man goes home after knee surgery with an opioid and gabapentin. He also takes a bedtime antihistamine for a cold. His wife notices loud, irregular snoring with long pauses on the second night and cannot rouse him easily. She calls emergency services. The combination of three sedating drugs, age and undiagnosed sleep apnea made a breathing problem far more likely than any single drug would have.

Scenario two: the long-term patient with a new pill

A fifty-five-year-old woman has taken a modest gabapentin dose for neuropathy for years and has been stable on a low-dose opioid after a back injury. Her gabapentin dose is raised during a flare while her kidney function has been quietly declining. Over a week she becomes steadily sleepier and has a near-fall. Her pharmacist catches the kidney issue during a refill review and asks her prescriber to adjust. A routine safeguard prevented a bigger problem.

Scenario three: the alcohol factor

A forty-two-year-old man takes an opioid and gabapentin after a fracture. At a family dinner, he has a few drinks “because it’s been a rough month.” Alcohol adds a third respiratory depressant and also reduces his awareness of how impaired he is. He falls asleep on the couch and is found unresponsive hours later. Recovery from episodes like this depends heavily on who is nearby and how fast they act. For more on this layer of risk, read gabapentin and alcohol.

Myths that make the combination more dangerous

“Gabapentin isn’t a controlled drug, so it can’t be that risky.”

Regulatory scheduling reflects abuse policy, not respiratory safety. The FDA required new respiratory depression warnings on gabapentin labeling precisely because the risk is real in vulnerable patients.

“I’m used to opioids, so I’m protected.”

Tolerance to breathing suppression develops, but incompletely and unpredictably, and adding another depressant can overwhelm it. Tolerance also disappears quickly after a break.

“If I feel fine, I’m fine.”

Respiratory depression is not reliably felt from the inside. By the time someone is aware that something is wrong, they may already be too sedated to act. That is why bystanders matter.

“Separating the doses by a few hours makes it safe.”

Spacing may soften overlapping peaks for some people, but it does not remove the combined effect, particularly with long-acting products or reduced kidney clearance. It is a question for your pharmacist, not a guarantee.

“Natural sleep aids are risk-free to add.”

Even products sold without a prescription can be sedating or can interact. Ask before adding anything, particularly at bedtime. Our article on oxycodone and sleep medications discusses how this layering happens.

Questions to ask your prescriber and pharmacist

1. Do both of you know that I take both medications, and who is responsible for monitoring the combination?
2. Is my gabapentin dose appropriate for my kidney function and age?
3. Do I have any lung conditions or sleep apnea that change the plan, and should I be screened?
4. What is the lowest dose of each drug that could control my symptoms, and when will we try to reduce them?
5. Should I have naloxone at home, and can someone show my family how to use it?
6. What over-the-counter products, supplements and drinks should I avoid?
7. What is the plan if I miss a dose or if my pain suddenly gets worse?
8. How and when will we stop one or both medications?

Coming off one or both drugs

Stopping either medication abruptly carries risks of its own. Opioid withdrawal is miserable and can drive people back to higher doses, while gabapentin withdrawal can bring anxiety, insomnia and, in vulnerable patients, seizures. Another subtle risk: if someone has stopped an opioid for a while and then restarts at their old dose, their tolerance has dropped and the same dose may be dangerous, especially combined with gabapentin. Work with your clinician on a taper for both and read gabapentin withdrawal and tapering for general principles.

Frequently asked questions

Is it dangerous to take gabapentin and opioids together?

It can be. The FDA warns that serious breathing difficulties may occur with gabapentinoids in people using opioids or with other respiratory risk factors. The risk is not identical for everyone, and prescribers sometimes use both intentionally with precautions.

Can I take them at the same time?

Follow your prescriber’s instructions. Do not combine, increase or change timing on your own. If you take them together, ask whether staggering the doses makes sense for your situation.

Does gabapentin by itself stop breathing?

Serious breathing problems with gabapentin alone appear much less common in healthy people, according to the FDA, but sleep-related breathing pauses were seen in one trial. People with lung disease, advanced age or kidney impairment may be more vulnerable even without opioids.

Does naloxone work for a gabapentin overdose?

Naloxone reverses opioids, not gabapentin. When both are involved, naloxone can restore some breathing, but emergency care is still essential because other sedatives remain active.

What about tramadol, codeine or other weaker opioids?

The warning applies to the opioid class. Weaker opioids still depress breathing, and combined sedation remains a concern. See gabapentin vs tramadol for more.

How long should I wait between doses of the two?

There is no universal rule. Your prescriber or pharmacist can recommend timing based on the formulations and your health. Avoid guessing.

Is pregabalin (Lyrica) safer in this respect?

No. The FDA warning covers both gabapentin and pregabalin. See pregabalin vs gabapentin and gabapentin vs Lyrica for fibromyalgia.

The bottom line

The combination of gabapentin and opioids is common, sometimes appropriate and measurably riskier than either drug alone for people with respiratory risk factors. The safest approach is deliberate prescribing, the lowest effective doses, no alcohol or extra sedatives, awareness of warning signs, a naloxone kit within reach and honest communication among patient, caregivers, pharmacist and prescribers. If you are uncertain about what you take, ask now rather than after a close call.

Sources and further reading

• FDA Drug Safety Communication: serious breathing problems with gabapentin and pregabalin
• Neurontin prescribing information (FDA)
• SAMHSA National Helpline
• MedlinePlus: Gabapentin

Medical disclaimer: This article is for general education and does not provide medical advice, diagnosis or treatment. If you suspect an overdose, call emergency services immediately. Do not start, change or stop any medication without consulting a qualified healthcare professional.